Analystreport

Nabriva Therapeutics PLC - (NASDAQ: NBRV) had its price target lowered by analysts at Northland Securities from $5.00 to $2.50. They now have an "outperform" rating on the stock.

Nabriva Therapeutics plc - Ordinary Shares  (NBRV) 
Last nabriva therapeutics plc - ordinary shares earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.nabriva.com/investor-relations